Cerenome
Business Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6420 S Levitt Green Blvd Ste 210, Housto...Phone Number
(210) 974-6900Website
www.cerenome.comRevenue
-Stock Symbol
CNSYIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Cerenome
Cerenome, Inc. is a clinical-stage oncology company focused on developing targeted therapies for central nervous system and other cancers, with a business model centered on advancing proprietary radiotherapeutic candidates through clinical development and future commercialization. The company also presents a broader integrated oncology platform that links therapeutics with diagnostics and clinical data capabilities, but its lead value proposition remains the development of cancer treatments based on rhenium-enabled radiotherapy approaches for difficult-to-treat malignancies. Its operating profile aligns most closely with a pharmaceutical developer rather than a healthcare provider or software business.Explore more
Cerenome Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cerenome your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cerenome
Check out if Cerenome is spiking on competitors!
Funding: Get notified immidiatlly once Cerenome has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Cerenome recently announced quarterly report
Website visits: Recent activity has been detected on your website
Cerenome, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Cerenome has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cerenome launches new products
Click to see if Cerenome had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Cerenome as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Cerenome is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cerenome is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cerenome.
Cerenome financials insights
Gather financial insights about Cerenome, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Debt
$20M
Cerenome News & Media
Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment
Capital will support continued CNSide® commercial scale-up and developmentCerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines
Cerenome highlights SNO/ASCO data showing REYOBIQ CSF distribution and safety, and CNSide’s potential to reduce monthly LM treatment costs by up to 47%.Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives
Cerenome signs in-network agreement with HCSC, expanding CNSide contracted coverage to ~153 million lives and exceeding its 2026 coverage goal.Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform
Scalable revenue cycle ecosystem designed to support anticipated billing volumes; CNSide assay billing to begin in Q3 2026 with accumulated 2026 backlog of tests and concurrent case billing Scalable revenue cycle ecosystem designed to support anticipated billing volumes; CNSide assay billing to begin in Q3 2026 with accumulated 2026 backlog of tests and concurrent case billing
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Cerenome
Sign Up For FreeTo access detailed company insights
Cerenome, Inc. is a clinical-stage oncology company focused on developing targeted therapies for central nervous system and other cancers, with a business model centered on advancing proprietary radiotherapeutic candidates through clinical development and future commercialization. The company also presents a broader integrated oncology platform tha... Read More
